Your browser doesn't support javascript.
loading
Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2, in patients with chronic kidney disease: A randomized trial.
He, YanLing; Pachori, Alok; Chen, Ping; Ma, Shenglin; Mendonza, Anisha E; Amer, Ahmed; Marbury, Thomas C; Hinder, Markus.
Afiliação
  • He Y; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Pachori A; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Chen P; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Ma S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Mendonza AE; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Amer A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Marbury TC; Orlando Clinical Research Center, Orlando, Florida, USA.
  • Hinder M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
Diabetes Obes Metab ; 23(5): 1182-1190, 2021 05.
Article em En | MEDLINE | ID: mdl-33512754
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article